Novel motif:38: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 14:42, 9 September 2013
name: | motif38_TCGNCA |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0034660 | ncRNA metabolic process | 4.096544e-10 |
GO:0045116 | protein neddylation | 2.203802e-9 |
GO:0032784 | regulation of transcription elongation, DNA-dependent | 2.291113e-9 |
GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation | 6.306323e-9 |
GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter | 1.673929e-8 |
GO:0060347 | heart trabecula formation | 4.199651e-8 |
GO:0016070 | RNA metabolic process | 4.482127e-8 |
GO:0006772 | thiamine metabolic process | 4.573574e-8 |
GO:0035356 | cellular triglyceride homeostasis | 4.828148e-8 |
GO:0046491 | L-methylmalonyl-CoA metabolic process | 4.964724e-8 |
GO:0000375 | RNA splicing, via transesterification reactions | 6.415137e-8 |
GO:0043543 | protein acylation | 6.902857e-8 |
GO:0034470 | ncRNA processing | 7.731127e-8 |
GO:0042574 | retinal metabolic process | 1.194842e-7 |
GO:0010467 | gene expression | 1.504464e-7 |
GO:0050908 | detection of light stimulus involved in visual perception | 2.496698e-7 |
GO:0060349 | bone morphogenesis | 2.933432e-7 |
GO:0018364 | peptidyl-glutamine methylation | 3.100553e-7 |
GO:0016180 | snRNA processing | 3.191075e-7 |
GO:0061384 | heart trabecular morphogenesis | 3.206316e-7 |
GO:0006473 | protein acetylation | 3.235060e-7 |
GO:0045651 | positive regulation of macrophage differentiation | 4.481335e-7 |
GO:0000414 | regulation of histone H3-K36 methylation | 4.675916e-7 |
GO:0006369 | termination of RNA polymerase II transcription | 4.985771e-7 |
GO:0006488 | dolichol-linked oligosaccharide biosynthetic process | 5.713573e-7 |
GO:0042488 | positive regulation of odontogenesis of dentine-containing tooth | 7.018545e-7 |
GO:0015887 | pantothenate transmembrane transport | 8.366751e-7 |
GO:0015878 | biotin transport | 8.366751e-7 |
GO:0034633 | retinol transport | 8.788569e-7 |
GO:0006475 | internal protein amino acid acetylation | 8.839438e-7 |
GO:0060611 | mammary gland fat development | 1.038089e-6 |
GO:0034645 | cellular macromolecule biosynthetic process | 1.073101e-6 |
GO:0032074 | negative regulation of nuclease activity | 1.333186e-6 |
GO:0016573 | histone acetylation | 1.340347e-6 |
GO:0006414 | translational elongation | 1.834803e-6 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 1.995098e-6 |
GO:0000398 | nuclear mRNA splicing, via spliceosome | 2.036316e-6 |
GO:0060923 | cardiac muscle cell fate commitment | 2.156875e-6 |
GO:0018205 | peptidyl-lysine modification | 2.292180e-6 |
GO:0042538 | hyperosmotic salinity response | 2.784097e-6 |
GO:0006412 | translation | 2.789625e-6 |
GO:0000738 | DNA catabolic process, exonucleolytic | 3.036996e-6 |
GO:0007195 | inhibition of adenylate cyclase activity by dopamine receptor signaling pathway | 3.319321e-6 |
GO:0018394 | peptidyl-lysine acetylation | 3.413772e-6 |
GO:0010626 | negative regulation of Schwann cell proliferation | 3.532232e-6 |
GO:0050434 | positive regulation of viral transcription | 3.818638e-6 |
GO:0006396 | RNA processing | 3.820127e-6 |
GO:0042696 | menarche | 4.043286e-6 |
GO:0018393 | internal peptidyl-lysine acetylation | 4.120499e-6 |
GO:0043967 | histone H4 acetylation | 4.163949e-6 |
GO:0022613 | ribonucleoprotein complex biogenesis | 4.540522e-6 |
GO:0006684 | sphingomyelin metabolic process | 4.694719e-6 |
GO:0016073 | snRNA metabolic process | 4.782071e-6 |
GO:0060343 | trabecula formation | 5.063894e-6 |
GO:0014888 | striated muscle adaptation | 5.250669e-6 |
GO:0060996 | dendritic spine development | 5.490741e-6 |
GO:0009785 | blue light signaling pathway | 5.558532e-6 |
GO:0034214 | protein hexamerization | 5.723100e-6 |
GO:0060348 | bone development | 5.969945e-6 |
GO:0009059 | macromolecule biosynthetic process | 6.136113e-6 |
GO:0021603 | cranial nerve formation | 6.582818e-6 |
GO:0090304 | nucleic acid metabolic process | 6.984060e-6 |
GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin | 9.141832e-6 |
GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity | 1.208206e-5 |
GO:0021517 | ventral spinal cord development | 1.274735e-5 |
GO:0000416 | positive regulation of histone H3-K36 methylation | 1.294641e-5 |
GO:0061383 | trabecula morphogenesis | 1.305858e-5 |
GO:0042723 | thiamine-containing compound metabolic process | 1.318981e-5 |
GO:0071843 | cellular component biogenesis at cellular level | 1.427753e-5 |
GO:0072301 | regulation of metanephric glomerular mesangial cell proliferation | 1.786263e-5 |
GO:0034389 | lipid particle organization | 1.885577e-5 |
GO:0016569 | covalent chromatin modification | 2.059355e-5 |
GO:0001958 | endochondral ossification | 2.060777e-5 |
GO:0006353 | transcription termination, DNA-dependent | 2.155780e-5 |
GO:0016570 | histone modification | 2.188473e-5 |
GO:0048665 | neuron fate specification | 2.284747e-5 |
GO:0010832 | negative regulation of myotube differentiation | 2.463764e-5 |
GO:0006493 | protein O-linked glycosylation | 2.771267e-5 |
GO:0072298 | regulation of metanephric glomerulus development | 2.956076e-5 |
GO:0032786 | positive regulation of transcription elongation, DNA-dependent | 2.956076e-5 |
GO:0046755 | non-lytic virus budding | 3.143828e-5 |
GO:0060997 | dendritic spine morphogenesis | 3.377438e-5 |
GO:0006013 | mannose metabolic process | 3.448917e-5 |
GO:0006596 | polyamine biosynthetic process | 3.747385e-5 |
GO:0008033 | tRNA processing | 4.070552e-5 |
GO:0060920 | pacemaker cell differentiation | 4.381660e-5 |
GO:0006172 | ADP biosynthetic process | 4.434479e-5 |
GO:0035470 | positive regulation of vascular wound healing | 5.060532e-5 |
GO:0014037 | Schwann cell differentiation | 5.175505e-5 |
GO:0043501 | skeletal muscle adaptation | 6.613306e-5 |
GO:0035721 | intraflagellar retrograde transport | 7.535828e-5 |
GO:0071105 | response to interleukin-11 | 7.988138e-5 |
GO:0031619 | homologous chromosome orientation involved in meiotic metaphase I plate congression | 7.988138e-5 |
GO:0072205 | metanephric collecting duct development | 8.063041e-5 |
GO:0014894 | response to denervation involved in regulation of muscle adaptation | 8.079916e-5 |
GO:0021759 | globus pallidus development | 8.093270e-5 |
GO:0010509 | polyamine homeostasis | 8.555527e-5 |
GO:0006427 | histidyl-tRNA aminoacylation | 8.555527e-5 |
GO:0014044 | Schwann cell development | 8.748055e-5 |
GO:0019673 | GDP-mannose metabolic process | 8.816900e-5 |
GO:0014874 | response to stimulus involved in regulation of muscle adaptation | 8.816900e-5 |
GO:0021506 | anterior neuropore closure | 9.401739e-5 |
GO:0071104 | response to interleukin-9 | 9.801778e-5 |
GO:0022011 | myelination in peripheral nervous system | 1.034580e-4 |
GO:0072044 | collecting duct development | 1.053575e-4 |
GO:0016072 | rRNA metabolic process | 1.070609e-4 |
GO:0001732 | formation of translation initiation complex | 1.130413e-4 |
GO:0048706 | embryonic skeletal system development | 1.153184e-4 |
GO:0032774 | RNA biosynthetic process | 1.167935e-4 |
GO:0090311 | regulation of protein deacetylation | 1.244142e-4 |
GO:0006420 | arginyl-tRNA aminoacylation | 1.246457e-4 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 1.277609e-4 |
GO:0007522 | visceral muscle development | 1.288217e-4 |
GO:0046782 | regulation of viral transcription | 1.320606e-4 |
GO:0003339 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 1.356263e-4 |
GO:0010735 | positive regulation of transcription via serum response element binding | 1.364743e-4 |
GO:0006415 | translational termination | 1.412453e-4 |
GO:0060350 | endochondral bone morphogenesis | 1.422056e-4 |
GO:0021892 | cerebral cortex GABAergic interneuron differentiation | 1.465584e-4 |
GO:0048343 | paraxial mesodermal cell fate commitment | 1.468045e-4 |
GO:0021871 | forebrain regionalization | 1.469389e-4 |
GO:0051764 | actin crosslink formation | 1.479365e-4 |
GO:0002209 | behavioral defense response | 1.486016e-4 |
GO:0021515 | cell differentiation in spinal cord | 1.507360e-4 |
GO:0042335 | cuticle development | 1.760122e-4 |
GO:0043503 | skeletal muscle fiber adaptation | 1.925420e-4 |
GO:0006364 | rRNA processing | 1.944280e-4 |
GO:0009637 | response to blue light | 1.970271e-4 |
GO:0072302 | negative regulation of metanephric glomerular mesangial cell proliferation | 1.991414e-4 |
GO:0061032 | visceral serous pericardium development | 1.991414e-4 |
GO:0060177 | regulation of angiotensin metabolic process | 2.034290e-4 |
GO:0006399 | tRNA metabolic process | 2.140327e-4 |
GO:0006354 | transcription elongation, DNA-dependent | 2.157663e-4 |
GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 2.163355e-4 |
GO:0035461 | vitamin transmembrane transport | 2.370145e-4 |
GO:0072124 | regulation of glomerular mesangial cell proliferation | 2.391531e-4 |
GO:0048701 | embryonic cranial skeleton morphogenesis | 2.410998e-4 |
GO:0072284 | metanephric S-shaped body morphogenesis | 2.466596e-4 |
GO:0016071 | mRNA metabolic process | 2.471812e-4 |
GO:0031064 | negative regulation of histone deacetylation | 2.485719e-4 |
GO:0072215 | regulation of metanephros development | 2.556616e-4 |
GO:0033692 | cellular polysaccharide biosynthetic process | 2.606258e-4 |
GO:0009145 | purine nucleoside triphosphate biosynthetic process | 2.616781e-4 |
GO:0042026 | protein refolding | 2.763888e-4 |
GO:0031591 | wybutosine biosynthetic process | 2.775898e-4 |
GO:0009153 | purine deoxyribonucleotide biosynthetic process | 2.863162e-4 |
GO:0051180 | vitamin transport | 2.909417e-4 |
GO:0072307 | regulation of metanephric nephron tubule epithelial cell differentiation | 2.939658e-4 |
GO:0006370 | mRNA capping | 2.947337e-4 |
GO:0010830 | regulation of myotube differentiation | 2.951737e-4 |
GO:0030388 | fructose 1,6-bisphosphate metabolic process | 2.977860e-4 |
GO:0090263 | positive regulation of canonical Wnt receptor signaling pathway | 2.986546e-4 |
GO:0043585 | nose morphogenesis | 3.002659e-4 |
GO:0034111 | negative regulation of homotypic cell-cell adhesion | 3.002659e-4 |
GO:0046653 | tetrahydrofolate metabolic process | 3.028174e-4 |
GO:0006595 | polyamine metabolic process | 3.048135e-4 |
GO:0021522 | spinal cord motor neuron differentiation | 3.119211e-4 |
GO:0090192 | regulation of glomerulus development | 3.239834e-4 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 3.245585e-4 |
GO:0006754 | ATP biosynthetic process | 3.356558e-4 |
GO:0042572 | retinol metabolic process | 3.437767e-4 |
GO:0010889 | regulation of sequestering of triglyceride | 3.464170e-4 |
GO:0072164 | mesonephric tubule development | 3.519450e-4 |
GO:0010890 | positive regulation of sequestering of triglyceride | 3.527479e-4 |
GO:0045830 | positive regulation of isotype switching | 3.700625e-4 |
GO:0021528 | commissural neuron differentiation in spinal cord | 3.748468e-4 |
GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion | 3.748468e-4 |
GO:0051182 | coenzyme transport | 3.774144e-4 |
GO:0010225 | response to UV-C | 3.823592e-4 |
GO:0061302 | smooth muscle cell-matrix adhesion | 3.877789e-4 |
GO:0072166 | posterior mesonephric tubule development | 3.913288e-4 |
GO:0003409 | optic cup structural organization | 3.950882e-4 |
GO:0021623 | oculomotor nerve formation | 3.950882e-4 |
GO:0003404 | optic vesicle morphogenesis | 3.950882e-4 |
GO:0001662 | behavioral fear response | 4.134877e-4 |
GO:0016126 | sterol biosynthetic process | 4.174818e-4 |
GO:0002679 | respiratory burst involved in defense response | 4.184235e-4 |
GO:0009142 | nucleoside triphosphate biosynthetic process | 4.309981e-4 |
GO:0009584 | detection of visible light | 4.327678e-4 |
GO:0031081 | nuclear pore distribution | 4.476223e-4 |
GO:0030970 | retrograde protein transport, ER to cytosol | 4.567782e-4 |
GO:0031063 | regulation of histone deacetylation | 4.624345e-4 |
GO:0009258 | 10-formyltetrahydrofolate catabolic process | 4.645422e-4 |
GO:0061084 | negative regulation of protein refolding | 4.653209e-4 |
GO:0002318 | myeloid progenitor cell differentiation | 4.653209e-4 |
GO:0042254 | ribosome biogenesis | 4.744529e-4 |
GO:0044240 | multicellular organismal lipid catabolic process | 4.943997e-4 |
GO:0048532 | anatomical structure arrangement | 5.064270e-4 |
GO:0009452 | RNA capping | 5.075081e-4 |
GO:0015742 | alpha-ketoglutarate transport | 5.083332e-4 |
GO:0051461 | positive regulation of corticotropin secretion | 5.122553e-4 |
GO:0055009 | atrial cardiac muscle tissue morphogenesis | 5.194314e-4 |
GO:0035136 | forelimb morphogenesis | 5.220424e-4 |
GO:0072178 | nephric duct morphogenesis | 5.224191e-4 |
GO:2000824 | negative regulation of androgen receptor activity | 5.569592e-4 |
GO:0001823 | mesonephros development | 5.569778e-4 |
GO:0032922 | circadian regulation of gene expression | 5.850985e-4 |
GO:0003209 | cardiac atrium morphogenesis | 5.858576e-4 |
GO:0044249 | cellular biosynthetic process | 5.907563e-4 |
GO:0021681 | cerebellar granular layer development | 6.023751e-4 |
GO:0007140 | male meiosis | 6.234140e-4 |
GO:0009206 | purine ribonucleoside triphosphate biosynthetic process | 6.514180e-4 |
GO:0060911 | cardiac cell fate commitment | 6.640604e-4 |
GO:0033602 | negative regulation of dopamine secretion | 6.703214e-4 |
GO:0006281 | DNA repair | 6.747393e-4 |
GO:0042073 | intraflagellar transport | 6.821692e-4 |
GO:0010159 | specification of organ position | 6.882925e-4 |
GO:0060430 | lung saccule development | 6.896590e-4 |
GO:0006622 | protein targeting to lysosome | 6.962376e-4 |
GO:0097107 | postsynaptic density assembly | 7.189345e-4 |
GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity | 7.189345e-4 |
GO:0060465 | pharynx development | 7.189345e-4 |
GO:0002418 | immune response to tumor cell | 7.189345e-4 |
GO:0048550 | negative regulation of pinocytosis | 7.238288e-4 |
GO:2000252 | negative regulation of feeding behavior | 7.238288e-4 |
GO:0035646 | endosome to melanosome transport | 7.238288e-4 |
GO:0002637 | regulation of immunoglobulin production | 7.372795e-4 |
GO:0048873 | homeostasis of number of cells within a tissue | 7.397343e-4 |
GO:0051295 | establishment of meiotic spindle localization | 7.554044e-4 |
GO:0006476 | protein deacetylation | 7.616903e-4 |
GO:0097045 | phosphatidylserine exposure on blood platelet | 7.799604e-4 |
GO:0052314 | phytoalexin metabolic process | 7.799604e-4 |
GO:0000389 | nuclear mRNA 3'-splice site recognition | 7.821999e-4 |
GO:0071394 | cellular response to testosterone stimulus | 7.904252e-4 |
GO:0034776 | response to histamine | 7.904252e-4 |
GO:0042776 | mitochondrial ATP synthesis coupled proton transport | 7.982297e-4 |
GO:0009311 | oligosaccharide metabolic process | 8.222582e-4 |
GO:0045814 | negative regulation of gene expression, epigenetic | 8.487110e-4 |
GO:0051095 | regulation of helicase activity | 8.506028e-4 |
GO:0040032 | post-embryonic body morphogenesis | 8.642599e-4 |
GO:0034637 | cellular carbohydrate biosynthetic process | 8.656266e-4 |
GO:0006139 | nucleobase-containing compound metabolic process | 8.811861e-4 |
GO:0008380 | RNA splicing | 8.907802e-4 |
GO:0019083 | viral transcription | 8.942188e-4 |
GO:0048210 | Golgi vesicle fusion to target membrane | 9.107285e-4 |
GO:0002478 | antigen processing and presentation of exogenous peptide antigen | 9.124839e-4 |
GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter | 9.256944e-4 |
GO:0002089 | lens morphogenesis in camera-type eye | 9.277676e-4 |
GO:0009058 | biosynthetic process | 9.289487e-4 |
GO:0090303 | positive regulation of wound healing | 9.298882e-4 |
GO:0010544 | negative regulation of platelet activation | 9.594008e-4 |
GO:0009226 | nucleotide-sugar biosynthetic process | 9.678551e-4 |
GO:0065001 | specification of axis polarity | 9.714064e-4 |
GO:0042596 | fear response | 9.721264e-4 |
GO:0019478 | D-amino acid catabolic process | 1.006199e-3 |
GO:0009201 | ribonucleoside triphosphate biosynthetic process | 1.026254e-3 |
GO:0045911 | positive regulation of DNA recombination | 1.049843e-3 |
GO:0048298 | positive regulation of isotype switching to IgA isotypes | 1.058675e-3 |
GO:0000725 | recombinational repair | 1.153989e-3 |
GO:0021520 | spinal cord motor neuron cell fate specification | 1.159663e-3 |
GO:0072125 | negative regulation of glomerular mesangial cell proliferation | 1.159786e-3 |
GO:0006379 | mRNA cleavage | 1.174927e-3 |
GO:0072337 | modified amino acid transport | 1.192322e-3 |
GO:0034959 | endothelin maturation | 1.205230e-3 |
GO:0010816 | calcitonin catabolic process | 1.205230e-3 |
GO:0010814 | substance P catabolic process | 1.205230e-3 |
GO:0035601 | protein deacylation | 1.217268e-3 |
GO:0006342 | chromatin silencing | 1.240014e-3 |
GO:0045090 | retroviral genome replication | 1.244479e-3 |
GO:0030309 | poly-N-acetyllactosamine metabolic process | 1.244479e-3 |
GO:0016051 | carbohydrate biosynthetic process | 1.266241e-3 |
GO:0003230 | cardiac atrium development | 1.272394e-3 |
GO:0014029 | neural crest formation | 1.304640e-3 |
GO:2000195 | negative regulation of female gonad development | 1.310209e-3 |
GO:0048148 | behavioral response to cocaine | 1.310209e-3 |
GO:0046502 | uroporphyrinogen III metabolic process | 1.324805e-3 |
GO:0021510 | spinal cord development | 1.331680e-3 |
GO:0031365 | N-terminal protein amino acid modification | 1.337885e-3 |
GO:0072176 | nephric duct development | 1.354755e-3 |
GO:0051152 | positive regulation of smooth muscle cell differentiation | 1.357505e-3 |
GO:0010866 | regulation of triglyceride biosynthetic process | 1.362796e-3 |
GO:0042450 | arginine biosynthetic process via ornithine | 1.366975e-3 |
GO:0014908 | myotube differentiation involved in skeletal muscle regeneration | 1.366975e-3 |
GO:0008049 | male courtship behavior | 1.366975e-3 |
GO:0051154 | negative regulation of striated muscle cell differentiation | 1.371585e-3 |
GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 1.375553e-3 |
GO:0016486 | peptide hormone processing | 1.390899e-3 |
GO:0071281 | cellular response to iron ion | 1.464914e-3 |
GO:0030311 | poly-N-acetyllactosamine biosynthetic process | 1.465735e-3 |
GO:0055014 | atrial cardiac muscle cell development | 1.482948e-3 |
GO:2000194 | regulation of female gonad development | 1.559635e-3 |
GO:0070368 | positive regulation of hepatocyte differentiation | 1.573642e-3 |
GO:0002175 | protein localization to paranode region of axon | 1.573642e-3 |
GO:0000379 | tRNA-type intron splice site recognition and cleavage | 1.573642e-3 |
GO:0060023 | soft palate development | 1.581717e-3 |
GO:0007096 | regulation of exit from mitosis | 1.599515e-3 |
GO:0002719 | negative regulation of cytokine production involved in immune response | 1.609387e-3 |
GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 1.609688e-3 |
GO:0016926 | protein desumoylation | 1.641293e-3 |
GO:0002002 | regulation of angiotensin levels in blood | 1.674074e-3 |
GO:0006351 | transcription, DNA-dependent | 1.682589e-3 |
GO:0046543 | development of secondary female sexual characteristics | 1.708149e-3 |
GO:0006695 | cholesterol biosynthetic process | 1.746037e-3 |
GO:0048806 | genitalia development | 1.785772e-3 |
GO:0072179 | nephric duct formation | 1.802251e-3 |
GO:0007132 | meiotic metaphase I | 1.804323e-3 |
GO:0043966 | histone H3 acetylation | 1.809776e-3 |
GO:0035115 | embryonic forelimb morphogenesis | 1.821653e-3 |
GO:0045083 | negative regulation of interleukin-12 biosynthetic process | 1.834075e-3 |
GO:0035269 | protein O-linked mannosylation | 1.881446e-3 |
GO:0002003 | angiotensin maturation | 1.881446e-3 |
GO:0051323 | metaphase | 1.891669e-3 |
GO:0009301 | snRNA transcription | 1.895885e-3 |
GO:0032066 | nucleolus to nucleoplasm transport | 1.895885e-3 |
GO:0007549 | dosage compensation | 1.907446e-3 |
GO:0007141 | male meiosis I | 2.002170e-3 |
GO:0048102 | autophagic cell death | 2.006251e-3 |
GO:0043624 | cellular protein complex disassembly | 2.021291e-3 |
GO:0048793 | pronephros development | 2.026832e-3 |
GO:2000594 | positive regulation of metanephric DCT cell differentiation | 2.106443e-3 |
GO:0072305 | negative regulation of mesenchymal stem cell apoptosis involved in metanephric nephron morphogenesis | 2.106443e-3 |
GO:0039003 | pronephric field specification | 2.106443e-3 |
GO:0006760 | folic acid-containing compound metabolic process | 2.199800e-3 |
GO:0072180 | mesonephric duct morphogenesis | 2.252858e-3 |
GO:2000378 | negative regulation of reactive oxygen species metabolic process | 2.305218e-3 |
GO:0001842 | neural fold formation | 2.315815e-3 |
GO:0009152 | purine ribonucleotide biosynthetic process | 2.319538e-3 |
GO:0006545 | glycine biosynthetic process | 2.327981e-3 |
GO:0060409 | positive regulation of acetylcholine metabolic process | 2.392128e-3 |
GO:0042664 | negative regulation of endodermal cell fate specification | 2.442575e-3 |
GO:0060921 | sinoatrial node cell differentiation | 2.442575e-3 |
GO:0060975 | cardioblast migration to the midline involved in heart field formation | 2.442575e-3 |
GO:0035481 | positive regulation of Notch signaling pathway involved in heart induction | 2.442575e-3 |
GO:0003259 | cardioblast anterior-lateral migration | 2.442575e-3 |
GO:0003236 | sinus venosus morphogenesis | 2.442575e-3 |
GO:0003210 | cardiac atrium formation | 2.442575e-3 |
GO:0003241 | growth involved in heart morphogenesis | 2.442575e-3 |
GO:2000249 | regulation of actin cytoskeleton reorganization | 2.463779e-3 |
GO:0039020 | pronephric nephron tubule development | 2.543691e-3 |
GO:0035565 | regulation of pronephros size | 2.543691e-3 |
GO:0032006 | regulation of TOR signaling cascade | 2.553032e-3 |
GO:0060976 | coronary vasculature development | 2.561003e-3 |
GO:0000724 | double-strand break repair via homologous recombination | 2.567432e-3 |
GO:0030421 | defecation | 2.569719e-3 |
GO:0048010 | vascular endothelial growth factor receptor signaling pathway | 2.574681e-3 |
GO:0070170 | regulation of tooth mineralization | 2.654180e-3 |
GO:0051569 | regulation of histone H3-K4 methylation | 2.702072e-3 |
GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter | 2.723353e-3 |
GO:0007212 | dopamine receptor signaling pathway | 2.738851e-3 |
GO:0021526 | medial motor column neuron differentiation | 2.745747e-3 |
GO:0051096 | positive regulation of helicase activity | 2.749113e-3 |
GO:0018279 | protein N-linked glycosylation via asparagine | 2.839039e-3 |
GO:0006289 | nucleotide-excision repair | 2.839458e-3 |
GO:0045649 | regulation of macrophage differentiation | 2.859895e-3 |
GO:0090161 | Golgi ribbon formation | 2.943918e-3 |
GO:0007422 | peripheral nervous system development | 3.000200e-3 |
GO:0030103 | vasopressin secretion | 3.012195e-3 |
GO:0043622 | cortical microtubule organization | 3.012195e-3 |
GO:0014813 | satellite cell commitment | 3.012195e-3 |
GO:0006424 | glutamyl-tRNA aminoacylation | 3.012195e-3 |
GO:0006051 | N-acetylmannosamine metabolic process | 3.012195e-3 |
GO:0046732 | active induction of host immune response by virus | 3.058117e-3 |
GO:0006467 | protein thiol-disulfide exchange | 3.108787e-3 |
GO:0006366 | transcription from RNA polymerase II promoter | 3.123529e-3 |
GO:0046323 | glucose import | 3.133536e-3 |
GO:0000415 | negative regulation of histone H3-K36 methylation | 3.133536e-3 |
GO:0007623 | circadian rhythm | 3.141367e-3 |
GO:0021782 | glial cell development | 3.153916e-3 |
GO:2000786 | positive regulation of autophagic vacuole assembly | 3.173128e-3 |
GO:0003168 | cardiac Purkinje fiber cell differentiation | 3.173128e-3 |
GO:0060929 | atrioventricular node cell fate commitment | 3.173128e-3 |
GO:0060928 | atrioventricular node cell development | 3.173128e-3 |
GO:0003342 | proepicardium development | 3.173128e-3 |
GO:0045818 | negative regulation of glycogen catabolic process | 3.173128e-3 |
GO:0050883 | musculoskeletal movement, spinal reflex action | 3.182616e-3 |
GO:0071169 | establishment of protein localization to chromatin | 3.182616e-3 |
GO:0006756 | AMP phosphorylation | 3.182616e-3 |
GO:0022618 | ribonucleoprotein complex assembly | 3.184004e-3 |
GO:0018206 | peptidyl-methionine modification | 3.219215e-3 |
GO:0034641 | cellular nitrogen compound metabolic process | 3.292784e-3 |
GO:0010624 | regulation of Schwann cell proliferation | 3.378098e-3 |
GO:0010388 | cullin deneddylation | 3.393334e-3 |
GO:0043932 | ossification involved in bone remodeling | 3.441957e-3 |
GO:0016575 | histone deacetylation | 3.466665e-3 |
GO:0044088 | regulation of vacuole organization | 3.500999e-3 |
GO:0008216 | spermidine metabolic process | 3.500999e-3 |
GO:0001757 | somite specification | 3.535519e-3 |
GO:0006173 | dADP biosynthetic process | 3.606589e-3 |
GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation | 3.625659e-3 |
GO:0042558 | pteridine-containing compound metabolic process | 3.650253e-3 |
GO:0007090 | regulation of S phase of mitotic cell cycle | 3.712220e-3 |
GO:0015942 | formate metabolic process | 3.769183e-3 |
GO:0002149 | hypochlorous acid biosynthetic process | 3.769183e-3 |
GO:0042552 | myelination | 3.778312e-3 |
GO:0035518 | histone H2A monoubiquitination | 4.006737e-3 |
GO:0065004 | protein-DNA complex assembly | 4.020247e-3 |
GO:0048193 | Golgi vesicle transport | 4.020778e-3 |
GO:0010871 | negative regulation of receptor biosynthetic process | 4.080934e-3 |
GO:0045191 | regulation of isotype switching | 4.124919e-3 |
GO:0033076 | isoquinoline alkaloid metabolic process | 4.140354e-3 |
GO:0048704 | embryonic skeletal system morphogenesis | 4.210844e-3 |
GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter | 4.254062e-3 |
GO:0014034 | neural crest cell fate commitment | 4.254062e-3 |
GO:0042759 | long-chain fatty acid biosynthetic process | 4.274023e-3 |
GO:0060662 | salivary gland cavitation | 4.354459e-3 |
GO:0048170 | positive regulation of long-term neuronal synaptic plasticity | 4.485124e-3 |
GO:0090312 | positive regulation of protein deacetylation | 4.540970e-3 |
GO:0001886 | endothelial cell morphogenesis | 4.579025e-3 |
GO:0006487 | protein N-linked glycosylation | 4.613427e-3 |
GO:0072003 | kidney rudiment formation | 4.680047e-3 |
GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity | 4.721049e-3 |
GO:0033153 | T cell receptor V(D)J recombination | 4.721695e-3 |
GO:0045657 | positive regulation of monocyte differentiation | 4.739243e-3 |
GO:0035112 | genitalia morphogenesis | 4.745158e-3 |
GO:0046778 | modification by virus of host mRNA processing | 4.763222e-3 |
GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine | 4.763222e-3 |
GO:0072199 | regulation of mesenchymal cell proliferation involved in ureter development | 4.813766e-3 |
GO:0070669 | response to interleukin-2 | 4.814202e-3 |
GO:0010936 | negative regulation of macrophage cytokine production | 5.093912e-3 |
GO:0019058 | viral infectious cycle | 5.164672e-3 |
GO:0033088 | negative regulation of immature T cell proliferation in thymus | 5.170869e-3 |
GO:0090084 | negative regulation of inclusion body assembly | 5.175463e-3 |
GO:0048341 | paraxial mesoderm formation | 5.182519e-3 |
GO:0048935 | peripheral nervous system neuron development | 5.199638e-3 |
GO:0015879 | carnitine transport | 5.217092e-3 |
GO:0016032 | viral reproduction | 5.230179e-3 |
GO:0006711 | estrogen catabolic process | 5.244430e-3 |
GO:0009098 | leucine biosynthetic process | 5.244430e-3 |
GO:0006550 | isoleucine catabolic process | 5.244430e-3 |
GO:0000088 | mitotic prophase | 5.244430e-3 |
GO:0030539 | male genitalia development | 5.304526e-3 |
GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity | 5.337221e-3 |
GO:0070172 | positive regulation of tooth mineralization | 5.426199e-3 |
GO:0042663 | regulation of endodermal cell fate specification | 5.426199e-3 |
GO:0032796 | uropod organization | 5.449087e-3 |
GO:0033555 | multicellular organismal response to stress | 5.475820e-3 |
GO:0090207 | regulation of triglyceride metabolic process | 5.485902e-3 |
GO:0045948 | positive regulation of translational initiation | 5.491832e-3 |
GO:0043241 | protein complex disassembly | 5.625048e-3 |
GO:0009948 | anterior/posterior axis specification | 5.654105e-3 |
GO:0006807 | nitrogen compound metabolic process | 5.729219e-3 |
GO:0019884 | antigen processing and presentation of exogenous antigen | 5.744874e-3 |
GO:0048663 | neuron fate commitment | 5.849313e-3 |
GO:0043491 | protein kinase B signaling cascade | 5.927801e-3 |
GO:0007418 | ventral midline development | 5.930440e-3 |
GO:0042886 | amide transport | 5.991706e-3 |
GO:0033205 | cell cycle cytokinesis | 5.995101e-3 |
GO:0006334 | nucleosome assembly | 6.024955e-3 |
GO:0045749 | negative regulation of S phase of mitotic cell cycle | 6.074596e-3 |
GO:0009956 | radial pattern formation | 6.075756e-3 |
GO:0006401 | RNA catabolic process | 6.167151e-3 |
GO:0060708 | spongiotrophoblast differentiation | 6.195424e-3 |
GO:0021773 | striatal medium spiny neuron differentiation | 6.242485e-3 |
GO:0018916 | nitrobenzene metabolic process | 6.256099e-3 |
GO:0060158 | activation of phospholipase C activity by dopamine receptor signaling pathway | 6.268280e-3 |
GO:0032007 | negative regulation of TOR signaling cascade | 6.307558e-3 |
GO:0090138 | regulation of actin cytoskeleton organization by cell-cell adhesion | 6.392700e-3 |
GO:0061157 | mRNA destabilization | 6.392700e-3 |
GO:0010609 | posttranscriptional regulation of gene expression by mRNA localization | 6.392700e-3 |
GO:0008295 | spermidine biosynthetic process | 6.392700e-3 |
GO:0043456 | regulation of pentose-phosphate shunt | 6.432480e-3 |
GO:0018872 | arsonoacetate metabolic process | 6.432480e-3 |
GO:0018192 | enzyme active site formation via L-cysteine persulfide | 6.432480e-3 |
GO:0001519 | peptide amidation | 6.432480e-3 |
GO:0042278 | purine nucleoside metabolic process | 6.458174e-3 |
GO:0009223 | pyrimidine deoxyribonucleotide catabolic process | 6.554178e-3 |
GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway | 6.652908e-3 |
GO:0035229 | positive regulation of glutamate-cysteine ligase activity | 6.652908e-3 |
GO:0000115 | regulation of transcription involved in S phase of mitotic cell cycle | 6.652908e-3 |
GO:0032425 | positive regulation of mismatch repair | 6.696695e-3 |
GO:0016344 | meiotic chromosome movement towards spindle pole | 6.696695e-3 |
GO:0045085 | negative regulation of interleukin-2 biosynthetic process | 6.795887e-3 |
GO:0035924 | cellular response to vascular endothelial growth factor stimulus | 6.846877e-3 |
GO:0002357 | defense response to tumor cell | 6.861052e-3 |
GO:0006310 | DNA recombination | 6.942434e-3 |
GO:0043500 | muscle adaptation | 7.015072e-3 |
GO:0016568 | chromatin modification | 7.068658e-3 |
GO:0060459 | left lung development | 7.098320e-3 |
GO:0032793 | positive regulation of CREB transcription factor activity | 7.308668e-3 |
GO:0002320 | lymphoid progenitor cell differentiation | 7.366881e-3 |
GO:0045730 | respiratory burst | 7.395847e-3 |
GO:0006591 | ornithine metabolic process | 7.404910e-3 |
GO:0071955 | recycling endosome to Golgi transport | 7.447272e-3 |
GO:0034499 | late endosome to Golgi transport | 7.447272e-3 |
GO:0051958 | methotrexate transport | 7.487015e-3 |
GO:0022616 | DNA strand elongation | 7.503302e-3 |
GO:0045655 | regulation of monocyte differentiation | 7.573096e-3 |
GO:0006986 | response to unfolded protein | 7.691339e-3 |
GO:0043414 | macromolecule methylation | 7.779437e-3 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 7.802182e-3 |
GO:0043687 | post-translational protein modification | 7.873852e-3 |
GO:0044264 | cellular polysaccharide metabolic process | 7.928057e-3 |
GO:0090083 | regulation of inclusion body assembly | 8.007114e-3 |
GO:0022601 | menstrual cycle phase | 8.010137e-3 |
GO:0051006 | positive regulation of lipoprotein lipase activity | 8.010534e-3 |
GO:0009312 | oligosaccharide biosynthetic process | 8.028216e-3 |
GO:2001014 | regulation of skeletal muscle cell differentiation | 8.038700e-3 |
GO:0045008 | depyrimidination | 8.060212e-3 |
GO:0033084 | regulation of immature T cell proliferation in thymus | 8.092252e-3 |
GO:0002016 | regulation of blood volume by renin-angiotensin | 8.092252e-3 |
GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport | 8.114244e-3 |
GO:0016241 | regulation of macroautophagy | 8.114244e-3 |
GO:0042508 | tyrosine phosphorylation of Stat1 protein | 8.165623e-3 |
GO:0008653 | lipopolysaccharide metabolic process | 8.175644e-3 |
GO:0001574 | ganglioside biosynthetic process | 8.190799e-3 |
GO:0002121 | inter-male aggressive behavior | 8.358904e-3 |
GO:0042481 | regulation of odontogenesis | 8.452258e-3 |
GO:0060304 | regulation of phosphatidylinositol dephosphorylation | 8.483312e-3 |
GO:0060712 | spongiotrophoblast layer development | 8.579853e-3 |
GO:0048524 | positive regulation of viral reproduction | 8.658431e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0030488 | tRNA methylation | 6.014685e-26 |
GO:0006400 | tRNA modification | 8.243305e-20 |
GO:0001510 | RNA methylation | 1.485819e-19 |
GO:0009451 | RNA modification | 1.802086e-16 |
GO:0034382 | chylomicron remnant clearance | 2.329724e-13 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 1.144491e-12 |
GO:0034470 | ncRNA processing | 1.587349e-12 |
GO:0010172 | embryonic body morphogenesis | 1.663152e-12 |
GO:0034660 | ncRNA metabolic process | 3.304119e-12 |
GO:0044260 | cellular macromolecule metabolic process | 5.212932e-12 |
GO:0006399 | tRNA metabolic process | 5.394511e-12 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 1.094119e-11 |
GO:0090304 | nucleic acid metabolic process | 1.479739e-11 |
GO:0010984 | regulation of lipoprotein particle clearance | 1.800928e-11 |
GO:0045717 | negative regulation of fatty acid biosynthetic process | 2.134875e-11 |
GO:0008033 | tRNA processing | 6.648943e-11 |
GO:0051005 | negative regulation of lipoprotein lipase activity | 1.036692e-10 |
GO:0010467 | gene expression | 2.814905e-10 |
GO:0034447 | very-low-density lipoprotein particle clearance | 3.480377e-10 |
GO:0010900 | negative regulation of phosphatidylcholine catabolic process | 5.978850e-10 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 6.480664e-10 |
GO:0050823 | peptide antigen stabilization | 6.480664e-10 |
GO:0001843 | neural tube closure | 4.812912e-9 |
GO:0045922 | negative regulation of fatty acid metabolic process | 5.043861e-9 |
GO:2000772 | regulation of cellular senescence | 6.553191e-9 |
GO:0033239 | negative regulation of cellular amine metabolic process | 6.680472e-9 |
GO:0050995 | negative regulation of lipid catabolic process | 1.522052e-8 |
GO:0060606 | tube closure | 1.522893e-8 |
GO:0016070 | RNA metabolic process | 2.009505e-8 |
GO:0060192 | negative regulation of lipase activity | 2.279486e-8 |
GO:0006412 | translation | 3.403712e-8 |
GO:0090398 | cellular senescence | 3.520555e-8 |
GO:0034645 | cellular macromolecule biosynthetic process | 4.509837e-8 |
GO:0060696 | regulation of phospholipid catabolic process | 5.358610e-8 |
GO:0009059 | macromolecule biosynthetic process | 1.140013e-7 |
GO:0032481 | positive regulation of type I interferon production | 1.624117e-7 |
GO:0048261 | negative regulation of receptor-mediated endocytosis | 1.711187e-7 |
GO:0014020 | primary neural tube formation | 1.881285e-7 |
GO:0021508 | floor plate formation | 2.349954e-7 |
GO:0006396 | RNA processing | 3.788040e-7 |
GO:0003341 | cilium movement | 4.016726e-7 |
GO:0032375 | negative regulation of cholesterol transport | 4.326401e-7 |
GO:0051973 | positive regulation of telomerase activity | 5.453098e-7 |
GO:0006139 | nucleobase-containing compound metabolic process | 8.564394e-7 |
GO:0031507 | heterochromatin formation | 1.519862e-6 |
GO:0033344 | cholesterol efflux | 1.641314e-6 |
GO:0032203 | telomere formation via telomerase | 1.695636e-6 |
GO:0043170 | macromolecule metabolic process | 1.970302e-6 |
GO:0021506 | anterior neuropore closure | 2.757753e-6 |
GO:0055003 | cardiac myofibril assembly | 3.532091e-6 |
GO:0035986 | senescence-associated heterochromatin focus formation | 3.897012e-6 |
GO:2000774 | positive regulation of cellular senescence | 3.897012e-6 |
GO:0090402 | oncogene-induced senescence | 3.897012e-6 |
GO:0033505 | floor plate morphogenesis | 4.351835e-6 |
GO:0010724 | regulation of definitive erythrocyte differentiation | 4.589100e-6 |
GO:0048935 | peripheral nervous system neuron development | 4.938734e-6 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 1.033476e-5 |
GO:0006420 | arginyl-tRNA aminoacylation | 1.033476e-5 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.155246e-5 |
GO:0042254 | ribosome biogenesis | 1.194384e-5 |
GO:0033700 | phospholipid efflux | 1.420284e-5 |
GO:0071044 | histone mRNA catabolic process | 1.565371e-5 |
GO:0016926 | protein desumoylation | 2.046957e-5 |
GO:0007141 | male meiosis I | 2.086648e-5 |
GO:0035562 | negative regulation of chromatin binding | 2.195309e-5 |
GO:0007094 | mitotic cell cycle spindle assembly checkpoint | 2.271791e-5 |
GO:0016082 | synaptic vesicle priming | 2.327219e-5 |
GO:0071173 | spindle assembly checkpoint | 2.516977e-5 |
GO:0000075 | cell cycle checkpoint | 2.812396e-5 |
GO:0032374 | regulation of cholesterol transport | 3.073994e-5 |
GO:0071174 | mitotic cell cycle spindle checkpoint | 3.146040e-5 |
GO:0032479 | regulation of type I interferon production | 3.156345e-5 |
GO:0071843 | cellular component biogenesis at cellular level | 3.165704e-5 |
GO:0010982 | regulation of high-density lipoprotein particle clearance | 3.291532e-5 |
GO:0031577 | spindle checkpoint | 3.896599e-5 |
GO:0055006 | cardiac cell development | 4.045729e-5 |
GO:0006364 | rRNA processing | 4.048848e-5 |
GO:0032488 | Cdc42 protein signal transduction | 4.275151e-5 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 4.325582e-5 |
GO:0010897 | negative regulation of triglyceride catabolic process | 4.325582e-5 |
GO:0021603 | cranial nerve formation | 4.560124e-5 |
GO:0034380 | high-density lipoprotein particle assembly | 4.582740e-5 |
GO:0019047 | provirus integration | 4.664971e-5 |
GO:0042273 | ribosomal large subunit biogenesis | 4.861681e-5 |
GO:0090234 | regulation of kinetochore assembly | 4.976069e-5 |
GO:0090169 | regulation of spindle assembly | 4.976069e-5 |
GO:0071156 | regulation of cell cycle arrest | 5.385355e-5 |
GO:0071105 | response to interleukin-11 | 5.405303e-5 |
GO:0033205 | cell cycle cytokinesis | 5.695210e-5 |
GO:0007031 | peroxisome organization | 5.860941e-5 |
GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry | 5.943798e-5 |
GO:0007418 | ventral midline development | 5.943798e-5 |
GO:0090224 | regulation of spindle organization | 6.266626e-5 |
GO:0014816 | satellite cell differentiation | 6.812737e-5 |
GO:0022613 | ribonucleoprotein complex biogenesis | 7.062425e-5 |
GO:0034381 | plasma lipoprotein particle clearance | 7.084486e-5 |
GO:0090343 | positive regulation of cell aging | 7.989694e-5 |
GO:0006807 | nitrogen compound metabolic process | 8.088541e-5 |
GO:0031576 | G2/M transition checkpoint | 8.368678e-5 |
GO:0044237 | cellular metabolic process | 8.487739e-5 |
GO:0032092 | positive regulation of protein binding | 8.592619e-5 |
GO:0045919 | positive regulation of cytolysis | 8.609557e-5 |
GO:0006974 | response to DNA damage stimulus | 8.755885e-5 |
GO:0010667 | negative regulation of cardiac muscle cell apoptosis | 8.801422e-5 |
GO:0000281 | cytokinesis after mitosis | 9.575990e-5 |
GO:0016072 | rRNA metabolic process | 1.054057e-4 |
GO:0032202 | telomere assembly | 1.073619e-4 |
GO:0008334 | histone mRNA metabolic process | 1.117996e-4 |
GO:0031572 | G2/M transition DNA damage checkpoint | 1.147072e-4 |
GO:0051972 | regulation of telomerase activity | 1.217353e-4 |
GO:0003409 | optic cup structural organization | 1.373012e-4 |
GO:0021623 | oculomotor nerve formation | 1.373012e-4 |
GO:0003404 | optic vesicle morphogenesis | 1.373012e-4 |
GO:0033238 | regulation of cellular amine metabolic process | 1.457825e-4 |
GO:0045806 | negative regulation of endocytosis | 1.536853e-4 |
GO:0032367 | intracellular cholesterol transport | 1.574028e-4 |
GO:0048936 | peripheral nervous system neuron axonogenesis | 1.642528e-4 |
GO:0015739 | sialic acid transport | 1.642528e-4 |
GO:0055013 | cardiac muscle cell development | 1.658934e-4 |
GO:0050994 | regulation of lipid catabolic process | 1.745905e-4 |
GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process | 1.931203e-4 |
GO:0071281 | cellular response to iron ion | 2.016481e-4 |
GO:0071544 | diphosphoinositol polyphosphate catabolic process | 2.018037e-4 |
GO:0061302 | smooth muscle cell-matrix adhesion | 2.079349e-4 |
GO:0032369 | negative regulation of lipid transport | 2.145965e-4 |
GO:0090102 | cochlea development | 2.208468e-4 |
GO:2000036 | regulation of stem cell maintenance | 2.267939e-4 |
GO:0003339 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 2.305822e-4 |
GO:0051586 | positive regulation of dopamine uptake | 2.323937e-4 |
GO:0034201 | response to oleic acid | 2.544618e-4 |
GO:0010989 | negative regulation of low-density lipoprotein particle clearance | 2.654625e-4 |
GO:0035461 | vitamin transmembrane transport | 3.034993e-4 |
GO:0048259 | regulation of receptor-mediated endocytosis | 3.080201e-4 |
GO:0021520 | spinal cord motor neuron cell fate specification | 3.254469e-4 |
GO:0032465 | regulation of cytokinesis | 3.297659e-4 |
GO:0048255 | mRNA stabilization | 3.324910e-4 |
GO:0043248 | proteasome assembly | 3.763868e-4 |
GO:0006683 | galactosylceramide catabolic process | 3.857465e-4 |
GO:0042268 | regulation of cytolysis | 4.098151e-4 |
GO:0010002 | cardioblast differentiation | 4.323358e-4 |
GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I | 4.336065e-4 |
GO:0071340 | skeletal muscle nicotinic acetylcholine receptor clustering | 4.339203e-4 |
GO:0032368 | regulation of lipid transport | 4.471727e-4 |
GO:0006413 | translational initiation | 4.677553e-4 |
GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter | 4.754510e-4 |
GO:0046599 | regulation of centriole replication | 4.813510e-4 |
GO:0006907 | pinocytosis | 4.813510e-4 |
GO:0006351 | transcription, DNA-dependent | 4.958886e-4 |
GO:0060620 | regulation of cholesterol import | 4.966546e-4 |
GO:0007569 | cell aging | 5.279026e-4 |
GO:0030240 | skeletal muscle thin filament assembly | 5.405023e-4 |
GO:0015780 | nucleotide-sugar transport | 5.514304e-4 |
GO:0014866 | skeletal myofibril assembly | 5.561795e-4 |
GO:0010771 | negative regulation of cell morphogenesis involved in differentiation | 5.604759e-4 |
GO:0070172 | positive regulation of tooth mineralization | 5.688043e-4 |
GO:0000414 | regulation of histone H3-K36 methylation | 5.766240e-4 |
GO:0001522 | pseudouridine synthesis | 5.774164e-4 |
GO:0034375 | high-density lipoprotein particle remodeling | 5.862257e-4 |
GO:0070170 | regulation of tooth mineralization | 5.963001e-4 |
GO:0090342 | regulation of cell aging | 5.971398e-4 |
GO:0051099 | positive regulation of binding | 6.045701e-4 |
GO:0032774 | RNA biosynthetic process | 6.232589e-4 |
GO:0042304 | regulation of fatty acid biosynthetic process | 6.429737e-4 |
GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 6.576221e-4 |
GO:0072368 | regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter | 6.651908e-4 |
GO:0072362 | regulation of glycolysis by negative regulation of transcription from RNA polymerase II promoter | 6.651908e-4 |
GO:0010665 | regulation of cardiac muscle cell apoptosis | 6.721729e-4 |
GO:0009083 | branched chain family amino acid catabolic process | 6.721729e-4 |
GO:0032728 | positive regulation of interferon-beta production | 6.823146e-4 |
GO:0001841 | neural tube formation | 7.283780e-4 |
GO:0051443 | positive regulation of ubiquitin-protein ligase activity | 7.399656e-4 |
GO:0033504 | floor plate development | 7.768519e-4 |
GO:0034446 | substrate adhesion-dependent cell spreading | 7.906149e-4 |
GO:0033211 | adiponectin-mediated signaling pathway | 8.241776e-4 |
GO:0006383 | transcription from RNA polymerase III promoter | 8.336162e-4 |
GO:0072560 | type B pancreatic cell maturation | 8.348199e-4 |
GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 8.348199e-4 |
GO:0045175 | basal protein localization | 8.348199e-4 |
GO:2000677 | regulation of transcription regulatory region DNA binding | 8.546644e-4 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 8.648524e-4 |
GO:0006427 | histidyl-tRNA aminoacylation | 8.859475e-4 |
GO:0015966 | diadenosine tetraphosphate biosynthetic process | 8.859475e-4 |
GO:0007049 | cell cycle | 8.929458e-4 |
GO:0048532 | anatomical structure arrangement | 9.052823e-4 |
GO:0042178 | xenobiotic catabolic process | 9.190307e-4 |
GO:0003337 | mesenchymal to epithelial transition involved in metanephros morphogenesis | 9.363078e-4 |
GO:0010564 | regulation of cell cycle process | 9.410652e-4 |
GO:0071104 | response to interleukin-9 | 9.556574e-4 |
GO:0030032 | lamellipodium assembly | 9.626216e-4 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 1.019400e-3 |
GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation | 1.019400e-3 |
GO:0071218 | cellular response to misfolded protein | 1.144151e-3 |
GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation | 1.144151e-3 |
GO:0070286 | axonemal dynein complex assembly | 1.222619e-3 |
GO:0071922 | regulation of cohesin localization to chromatin | 1.227849e-3 |
GO:0035284 | brain segmentation | 1.227849e-3 |
GO:0071712 | ER-associated misfolded protein catabolic process | 1.233108e-3 |
GO:0043414 | macromolecule methylation | 1.242626e-3 |
GO:0044249 | cellular biosynthetic process | 1.263810e-3 |
GO:0006259 | DNA metabolic process | 1.278469e-3 |
GO:0032467 | positive regulation of cytokinesis | 1.353330e-3 |
GO:0035051 | cardiac cell differentiation | 1.359885e-3 |
GO:0000239 | pachytene | 1.377846e-3 |
GO:0048570 | notochord morphogenesis | 1.495243e-3 |
GO:0002098 | tRNA wobble uridine modification | 1.544697e-3 |
GO:0000083 | regulation of transcription involved in G1/S phase of mitotic cell cycle | 1.588228e-3 |
GO:0032025 | response to cobalt ion | 1.641709e-3 |
GO:0006278 | RNA-dependent DNA replication | 1.655488e-3 |
GO:0060285 | ciliary cell motility | 1.687974e-3 |
GO:0032365 | intracellular lipid transport | 1.692714e-3 |
GO:0003151 | outflow tract morphogenesis | 1.710219e-3 |
GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway | 1.712520e-3 |
GO:0060248 | detection of cell density by contact stimulus involved in contact inhibition | 1.712520e-3 |
GO:0072285 | mesenchymal to epithelial transition involved in metanephric renal vesicle formation | 1.712520e-3 |
GO:0002368 | B cell cytokine production | 1.712520e-3 |
GO:0007371 | ventral midline determination | 1.712520e-3 |
GO:0048291 | isotype switching to IgG isotypes | 1.712520e-3 |
GO:0045875 | negative regulation of sister chromatid cohesion | 1.741521e-3 |
GO:0060621 | negative regulation of cholesterol import | 1.747419e-3 |
GO:0033554 | cellular response to stress | 1.793281e-3 |
GO:2000078 | positive regulation of type B pancreatic cell development | 1.828846e-3 |
GO:0051055 | negative regulation of lipid biosynthetic process | 1.858795e-3 |
GO:0060982 | coronary artery morphogenesis | 1.866575e-3 |
GO:0060071 | Wnt receptor signaling pathway, planar cell polarity pathway | 1.873966e-3 |
GO:0007093 | mitotic cell cycle checkpoint | 1.948415e-3 |
GO:0006929 | substrate-dependent cell migration | 1.970422e-3 |
GO:0051004 | regulation of lipoprotein lipase activity | 1.973828e-3 |
GO:0002483 | antigen processing and presentation of endogenous peptide antigen | 2.001298e-3 |
GO:0007352 | zygotic specification of dorsal/ventral axis | 2.053859e-3 |
GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning | 2.053859e-3 |
GO:0009637 | response to blue light | 2.088772e-3 |
GO:0006258 | UDP-glucose catabolic process | 2.088772e-3 |
GO:0061325 | cell proliferation involved in outflow tract morphogenesis | 2.196080e-3 |
GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis | 2.196080e-3 |
GO:0045833 | negative regulation of lipid metabolic process | 2.220538e-3 |
GO:0090189 | regulation of branching involved in ureteric bud morphogenesis | 2.274023e-3 |
GO:0021549 | cerebellum development | 2.284007e-3 |
GO:0055014 | atrial cardiac muscle cell development | 2.288215e-3 |
GO:0009081 | branched chain family amino acid metabolic process | 2.318091e-3 |
GO:0031058 | positive regulation of histone modification | 2.339262e-3 |
GO:0034377 | plasma lipoprotein particle assembly | 2.360862e-3 |
GO:0035912 | dorsal aorta morphogenesis | 2.420402e-3 |
GO:0030038 | contractile actin filament bundle assembly | 2.420402e-3 |
GO:0006488 | dolichol-linked oligosaccharide biosynthetic process | 2.420402e-3 |
GO:0021683 | cerebellar granular layer morphogenesis | 2.434002e-3 |
GO:0071711 | basement membrane organization | 2.574543e-3 |
GO:0016559 | peroxisome fission | 2.633846e-3 |
GO:0010735 | positive regulation of transcription via serum response element binding | 2.633846e-3 |
GO:0072175 | epithelial tube formation | 2.667653e-3 |
GO:0045085 | negative regulation of interleukin-2 biosynthetic process | 2.692362e-3 |
GO:0007389 | pattern specification process | 2.716673e-3 |
GO:0008654 | phospholipid biosynthetic process | 2.717177e-3 |
GO:0070370 | cellular heat acclimation | 2.752713e-3 |
GO:0071279 | cellular response to cobalt ion | 2.752713e-3 |
GO:0048621 | post-embryonic digestive tract morphogenesis | 2.752713e-3 |
GO:0010637 | negative regulation of mitochondrial fusion | 2.752713e-3 |
GO:0002317 | plasma cell differentiation | 2.752713e-3 |
GO:0042335 | cuticle development | 2.752713e-3 |
GO:0030031 | cell projection assembly | 2.776265e-3 |
GO:0035136 | forelimb morphogenesis | 2.836333e-3 |
GO:0031065 | positive regulation of histone deacetylation | 2.855041e-3 |
GO:0006260 | DNA replication | 2.859524e-3 |
GO:0021696 | cerebellar cortex morphogenesis | 2.863791e-3 |
GO:0060318 | definitive erythrocyte differentiation | 2.901011e-3 |
GO:0006418 | tRNA aminoacylation for protein translation | 2.917745e-3 |
GO:0043488 | regulation of mRNA stability | 2.948958e-3 |
GO:0051568 | histone H3-K4 methylation | 2.958390e-3 |
GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol | 3.004032e-3 |
GO:2000378 | negative regulation of reactive oxygen species metabolic process | 3.012544e-3 |
GO:0033044 | regulation of chromosome organization | 3.015384e-3 |
GO:0021658 | rhombomere 3 morphogenesis | 3.050147e-3 |
GO:0035148 | tube formation | 3.055424e-3 |
GO:0006284 | base-excision repair | 3.242861e-3 |
GO:0035966 | response to topologically incorrect protein | 3.254379e-3 |
GO:0006713 | glucocorticoid catabolic process | 3.267423e-3 |
GO:0090031 | positive regulation of steroid hormone biosynthetic process | 3.301872e-3 |
GO:0071168 | protein localization to chromatin | 3.398769e-3 |
GO:0002019 | regulation of renal output by angiotensin | 3.398769e-3 |
GO:0030149 | sphingolipid catabolic process | 3.422562e-3 |
GO:0003214 | cardiac left ventricle morphogenesis | 3.422562e-3 |
GO:0000380 | alternative nuclear mRNA splicing, via spliceosome | 3.498149e-3 |
GO:0046628 | positive regulation of insulin receptor signaling pathway | 3.680845e-3 |
GO:2000381 | negative regulation of mesoderm development | 3.695242e-3 |
GO:0006432 | phenylalanyl-tRNA aminoacylation | 3.695242e-3 |
GO:0048298 | positive regulation of isotype switching to IgA isotypes | 3.800252e-3 |
GO:0051098 | regulation of binding | 3.966673e-3 |
GO:0090312 | positive regulation of protein deacetylation | 4.041241e-3 |
GO:0008156 | negative regulation of DNA replication | 4.099660e-3 |
GO:0001838 | embryonic epithelial tube formation | 4.103674e-3 |
GO:0051310 | metaphase plate congression | 4.139258e-3 |
GO:0071882 | activation of phospholipase C activity by adrenergic receptor signaling pathway | 4.157337e-3 |
GO:0071881 | inhibition of adenylate cyclase activity by adrenergic receptor signaling pathway | 4.157337e-3 |
GO:0006597 | spermine biosynthetic process | 4.157337e-3 |
GO:0050711 | negative regulation of interleukin-1 secretion | 4.205597e-3 |
GO:0090103 | cochlea morphogenesis | 4.268413e-3 |
GO:0042733 | embryonic digit morphogenesis | 4.354873e-3 |
GO:0014034 | neural crest cell fate commitment | 4.450504e-3 |
GO:0023021 | termination of signal transduction | 4.450504e-3 |
GO:0034227 | tRNA thio-modification | 4.544110e-3 |
GO:0021915 | neural tube development | 4.550378e-3 |
GO:0035967 | cellular response to topologically incorrect protein | 4.561707e-3 |
GO:0043252 | sodium-independent organic anion transport | 4.564663e-3 |
GO:0060717 | chorion development | 4.564663e-3 |
GO:0000027 | ribosomal large subunit assembly | 4.564663e-3 |
GO:0032474 | otolith morphogenesis | 4.564663e-3 |
GO:0009438 | methylglyoxal metabolic process | 4.564663e-3 |
GO:0000416 | positive regulation of histone H3-K36 methylation | 4.564663e-3 |
GO:0061029 | eyelid development in camera-type eye | 4.601687e-3 |
GO:0090179 | planar cell polarity pathway involved in neural tube closure | 4.668748e-3 |
GO:0016331 | morphogenesis of embryonic epithelium | 4.723668e-3 |
GO:0006515 | misfolded or incompletely synthesized protein catabolic process | 4.758796e-3 |
GO:0021522 | spinal cord motor neuron differentiation | 4.800176e-3 |
GO:0035564 | regulation of kidney size | 4.937705e-3 |
GO:0031570 | DNA integrity checkpoint | 4.942021e-3 |
GO:0072077 | renal vesicle morphogenesis | 5.043030e-3 |
GO:0051302 | regulation of cell division | 5.094320e-3 |
GO:0002331 | pre-B cell allelic exclusion | 5.178926e-3 |
GO:0001539 | ciliary or flagellar motility | 5.186860e-3 |
GO:0071844 | cellular component assembly at cellular level | 5.258667e-3 |
GO:0072553 | terminal button organization | 5.352511e-3 |
GO:0031129 | inductive cell-cell signaling | 5.352511e-3 |
GO:0048704 | embryonic skeletal system morphogenesis | 5.361431e-3 |
GO:0010927 | cellular component assembly involved in morphogenesis | 5.412431e-3 |
GO:0021666 | rhombomere 5 formation | 5.484984e-3 |
GO:0021660 | rhombomere 3 formation | 5.484984e-3 |
GO:0044238 | primary metabolic process | 5.559641e-3 |
GO:0031063 | regulation of histone deacetylation | 5.566135e-3 |
GO:0048486 | parasympathetic nervous system development | 5.760169e-3 |
GO:0072283 | metanephric renal vesicle morphogenesis | 5.819134e-3 |
GO:0022037 | metencephalon development | 5.845462e-3 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 5.851402e-3 |
GO:0051303 | establishment of chromosome localization | 5.916924e-3 |
GO:0021707 | cerebellar granule cell differentiation | 5.964729e-3 |
GO:0043461 | proton-transporting ATP synthase complex assembly | 5.972178e-3 |
GO:0032418 | lysosome localization | 5.972178e-3 |
GO:0050713 | negative regulation of interleukin-1 beta secretion | 6.051596e-3 |
GO:0051584 | regulation of dopamine uptake | 6.051596e-3 |
GO:0051901 | positive regulation of mitochondrial depolarization | 6.061806e-3 |
GO:0043632 | modification-dependent macromolecule catabolic process | 6.192279e-3 |
GO:0043487 | regulation of RNA stability | 6.202088e-3 |
GO:0051351 | positive regulation of ligase activity | 6.210010e-3 |
GO:0000077 | DNA damage checkpoint | 6.290705e-3 |
GO:0019941 | modification-dependent protein catabolic process | 6.300669e-3 |
GO:0003002 | regionalization | 6.310216e-3 |
GO:0051569 | regulation of histone H3-K4 methylation | 6.319613e-3 |
GO:0021571 | rhombomere 5 development | 6.611248e-3 |
GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade | 6.710481e-3 |
GO:0051781 | positive regulation of cell division | 6.784913e-3 |
GO:0051639 | actin filament network formation | 6.795477e-3 |
GO:0032648 | regulation of interferon-beta production | 6.936684e-3 |
GO:2000380 | regulation of mesoderm development | 6.958628e-3 |
GO:0060384 | innervation | 6.958628e-3 |
GO:0019934 | cGMP-mediated signaling | 6.960283e-3 |
GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 7.023831e-3 |
GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis | 7.223242e-3 |
GO:0046513 | ceramide biosynthetic process | 7.229224e-3 |
GO:0090311 | regulation of protein deacetylation | 7.328952e-3 |
GO:0060048 | cardiac muscle contraction | 7.331158e-3 |
GO:0006685 | sphingomyelin catabolic process | 7.574206e-3 |
GO:0001881 | receptor recycling | 7.574206e-3 |
GO:2000679 | positive regulation of transcription regulatory region DNA binding | 7.632429e-3 |
GO:0032055 | negative regulation of translation in response to stress | 7.726446e-3 |
GO:0030903 | notochord development | 7.731731e-3 |
GO:0009058 | biosynthetic process | 7.740278e-3 |
GO:0016574 | histone ubiquitination | 8.077129e-3 |
GO:0030950 | establishment or maintenance of actin cytoskeleton polarity | 8.159765e-3 |
GO:0006011 | UDP-glucose metabolic process | 8.159765e-3 |
GO:0046474 | glycerophospholipid biosynthetic process | 8.212259e-3 |
GO:0008208 | C21-steroid hormone catabolic process | 8.266017e-3 |
GO:0038027 | apolipoprotein A-I-mediated signaling pathway | 8.266017e-3 |
GO:0050760 | negative regulation of thymidylate synthase biosynthetic process | 8.266017e-3 |
GO:0016191 | synaptic vesicle uncoating | 8.266017e-3 |
GO:0030262 | apoptotic nuclear change | 8.310305e-3 |
GO:0072040 | negative regulation of mesenchymal stem cell apoptosis involved in nephron morphogenesis | 8.335558e-3 |
GO:0046519 | sphingoid metabolic process | 8.385141e-3 |
GO:0043497 | regulation of protein heterodimerization activity | 8.529003e-3 |
GO:0060271 | cilium morphogenesis | 8.581855e-3 |
GO:0045212 | neurotransmitter receptor biosynthetic process | 8.687196e-3 |
GO:0051795 | positive regulation of catagen | 8.687196e-3 |
GO:0031167 | rRNA methylation | 8.687196e-3 |
GO:0060218 | hemopoietic stem cell differentiation | 8.839139e-3 |
GO:0032383 | regulation of intracellular cholesterol transport | 9.469616e-3 |
GO:0072267 | metanephric capsule specification | 9.469616e-3 |
GO:0035750 | protein localization to myelin sheath abaxonal region | 9.469616e-3 |
GO:0015887 | pantothenate transmembrane transport | 9.469616e-3 |
GO:0015878 | biotin transport | 9.469616e-3 |
GO:0006666 | 3-keto-sphinganine metabolic process | 9.469616e-3 |
GO:0007080 | mitotic metaphase plate congression | 9.668520e-3 |
GO:0045165 | cell fate commitment | 9.689172e-3 |
GO:0010948 | negative regulation of cell cycle process | 9.716148e-3 |
GO:0043056 | forward locomotion | 9.774357e-3 |
GO:0061015 | snRNA import into nucleus | 9.853612e-3 |
GO:0090241 | negative regulation of histone H4 acetylation | 9.853612e-3 |
GO:0034401 | regulation of transcription by chromatin organization | 9.853612e-3 |
GO:0006552 | leucine catabolic process | 9.853612e-3 |
GO:0018272 | protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine | 9.853612e-3 |
GO:0002542 | Factor XII activation | 9.853612e-3 |
GO:0015993 | molecular hydrogen transport | 9.853612e-3 |
GO:0032259 | methylation | 9.880968e-3 |
GO:0021557 | oculomotor nerve development | 1.003173e-2 |
GO:0071549 | cellular response to dexamethasone stimulus | 1.007539e-2 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 1.007539e-2 |
GO:0031497 | chromatin assembly | 1.008678e-2 |
GO:0055007 | cardiac muscle cell differentiation | 1.009877e-2 |
GO:0031017 | exocrine pancreas development | 1.010993e-2 |
GO:0016236 | macroautophagy | 1.011333e-2 |
GO:0015914 | phospholipid transport | 1.013693e-2 |
GO:0031848 | protection from non-homologous end joining at telomere | 1.020906e-2 |
GO:0032633 | interleukin-4 production | 1.020906e-2 |
GO:0001865 | NK T cell differentiation | 1.020906e-2 |
GO:0000089 | mitotic metaphase | 1.020906e-2 |
GO:0018205 | peptidyl-lysine modification | 1.025999e-2 |
GO:0034616 | response to laminar fluid shear stress | 1.038346e-2 |
GO:0006346 | methylation-dependent chromatin silencing | 1.056821e-2 |
GO:0048818 | positive regulation of hair follicle maturation | 1.064197e-2 |
GO:0032060 | bleb assembly | 1.068324e-2 |
GO:0000279 | M phase | 1.079469e-2 |
GO:0000087 | M phase of mitotic cell cycle | 1.088484e-2 |
GO:0034101 | erythrocyte homeostasis | 1.094771e-2 |
GO:0021681 | cerebellar granular layer development | 1.104834e-2 |
GO:0044085 | cellular component biogenesis | 1.113321e-2 |
GO:0002329 | pre-B cell differentiation | 1.115567e-2 |
GO:0010501 | RNA secondary structure unwinding | 1.137915e-2 |
GO:0051891 | positive regulation of cardioblast differentiation | 1.142711e-2 |
GO:0048285 | organelle fission | 1.152513e-2 |
GO:0021695 | cerebellar cortex development | 1.187139e-2 |
GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination | 1.194743e-2 |
GO:0071934 | thiamine transmembrane transport | 1.194743e-2 |
GO:0060339 | negative regulation of type I interferon-mediated signaling pathway | 1.194743e-2 |
GO:0035083 | cilium axoneme assembly | 1.194743e-2 |
GO:0006235 | dTTP biosynthetic process | 1.194743e-2 |
GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase | 1.194743e-2 |
GO:0002001 | renin secretion into blood stream | 1.194743e-2 |
GO:0061301 | cerebellum vasculature morphogenesis | 1.216309e-2 |
GO:0009107 | lipoate biosynthetic process | 1.216309e-2 |
GO:0046314 | phosphocreatine biosynthetic process | 1.216309e-2 |
GO:0046520 | sphingoid biosynthetic process | 1.221759e-2 |
GO:0003148 | outflow tract septum morphogenesis | 1.228316e-2 |
GO:0006414 | translational elongation | 1.233594e-2 |
GO:0060948 | cardiac vascular smooth muscle cell development | 1.239503e-2 |
GO:0006475 | internal protein amino acid acetylation | 1.249182e-2 |
GO:0061384 | heart trabecular morphogenesis | 1.250177e-2 |
GO:0000045 | autophagic vacuole assembly | 1.256110e-2 |
GO:0018393 | internal peptidyl-lysine acetylation | 1.278630e-2 |
GO:0035372 | protein localization to microtubule | 1.280777e-2 |
GO:0034976 | response to endoplasmic reticulum stress | 1.280921e-2 |
GO:0050774 | negative regulation of dendrite morphogenesis | 1.281273e-2 |
GO:0042637 | catagen | 1.291933e-2 |
GO:0031060 | regulation of histone methylation | 1.309857e-2 |
GO:0006921 | cellular component disassembly involved in apoptosis | 1.316247e-2 |
GO:0006506 | GPI anchor biosynthetic process | 1.317534e-2 |
GO:0021783 | preganglionic parasympathetic nervous system development | 1.318785e-2 |
GO:2000177 | regulation of neural precursor cell proliferation | 1.319368e-2 |
GO:0035567 | non-canonical Wnt receptor signaling pathway | 1.323284e-2 |
GO:0042147 | retrograde transport, endosome to Golgi | 1.333855e-2 |
GO:0006986 | response to unfolded protein | 1.345454e-2 |
GO:0010991 | negative regulation of SMAD protein complex assembly | 1.346598e-2 |
GO:0042384 | cilium assembly | 1.354007e-2 |
GO:0001780 | neutrophil homeostasis | 1.366021e-2 |
GO:0034502 | protein localization to chromosome | 1.403724e-2 |
GO:0006670 | sphingosine metabolic process | 1.425610e-2 |
GO:0045017 | glycerolipid biosynthetic process | 1.455584e-2 |
GO:0007199 | G-protein signaling, coupled to cGMP nucleotide second messenger | 1.476611e-2 |
GO:0007099 | centriole replication | 1.480940e-2 |
GO:0006473 | protein acetylation | 1.487164e-2 |
GO:0018394 | peptidyl-lysine acetylation | 1.489942e-2 |
GO:0045066 | regulatory T cell differentiation | 1.500389e-2 |
GO:0001839 | neural plate morphogenesis | 1.500389e-2 |
GO:0032914 | positive regulation of transforming growth factor beta1 production | 1.540174e-2 |
GO:0022007 | convergent extension involved in neural plate elongation | 1.540174e-2 |
GO:0072076 | nephrogenic mesenchyme development | 1.542511e-2 |
GO:0042697 | menopause | 1.542511e-2 |
GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 1.555079e-2 |
GO:0035022 | positive regulation of Rac protein signal transduction | 1.555079e-2 |
GO:0042278 | purine nucleoside metabolic process | 1.583032e-2 |
GO:0032376 | positive regulation of cholesterol transport | 1.585174e-2 |
GO:0060044 | negative regulation of cardiac muscle cell proliferation | 1.585174e-2 |
GO:0008380 | RNA splicing | 1.598744e-2 |
GO:0043393 | regulation of protein binding | 1.602417e-2 |
GO:0090209 | negative regulation of triglyceride metabolic process | 1.617829e-2 |
GO:0070508 | cholesterol import | 1.621290e-2 |
GO:0043249 | erythrocyte maturation | 1.621290e-2 |
GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis | 1.621290e-2 |
GO:0001708 | cell fate specification | 1.641299e-2 |
GO:0007140 | male meiosis | 1.676039e-2 |
GO:0033314 | mitotic cell cycle DNA replication checkpoint | 1.685046e-2 |
GO:0010756 | positive regulation of plasminogen activation | 1.685046e-2 |
GO:0007066 | female meiosis sister chromatid cohesion | 1.685046e-2 |
GO:0006844 | acyl carnitine transport | 1.685046e-2 |
GO:0052565 | response to defense-related host nitric oxide production | 1.718961e-2 |
GO:0051030 | snRNA transport | 1.718961e-2 |
GO:0046853 | inositol or phosphatidylinositol phosphorylation | 1.718961e-2 |
GO:0015959 | diadenosine polyphosphate metabolic process | 1.718961e-2 |
GO:0051580 | regulation of neurotransmitter uptake | 1.729255e-2 |
GO:0010893 | positive regulation of steroid biosynthetic process | 1.759287e-2 |
GO:0048665 | neuron fate specification | 1.774916e-2 |
GO:0007067 | mitosis | 1.781923e-2 |
GO:0071453 | cellular response to oxygen levels | 1.796380e-2 |
GO:0009057 | macromolecule catabolic process | 1.806330e-2 |
GO:0021513 | spinal cord dorsal/ventral patterning | 1.819756e-2 |